United Therapeutics Corporation (UTHR) Social Stream



United Therapeutics Corporation (UTHR): $186.31

0.93 (+0.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add UTHR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

UNITED THERAPEUTICS Corp (UTHR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering UTHR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 9 $276 $135 $234.375 $179.41 30.64%
2022-01-21 9 $276 $135 $235 $179.41 30.98%
2022-02-10 9 $276 $135 $235.625 $179.41 31.33%
2022-02-25 10 $276 $135 $235.625 $179.41 31.33%
2022-03-28 10 $275 $135 $223.75 $179.41 24.71%

The Trend in the Analyst Price Target


UTHR's average price target has moved up $89.53 over the prior 23 months.

Over the past 51 weeks, UTHR's average upside potential has been 15.59%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 11 276 122 214.56 184.99 15.98%
2021-09-18 11 276 130 231.89 200.08 15.9%
2021-11-08 9 276 135 235.00 202.09 16.28%
2022-01-21 9 276 135 235.00 200.06 17.46%
2022-01-21 8 276 135 235.00 200.06 17.46%

UTHR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 8 0 1 0 0 10

The Trend in the Broker Recommendations


Over the past 90 days, UTHR's average broker recommendation rating worsened by 0.17.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for UTHR as an investment opportunity.

  • In terms of how UNITED THERAPEUTICS Corp fares relative to all US stocks, note that its average analyst price target is greater than 635.78% of that group.
  • UNITED THERAPEUTICS Corp's upside potential (average analyst target price relative to current price) is greater than 96.18% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, UNITED THERAPEUTICS Corp's number of analysts covering the stock is higher than 539.16% of them.
  • In the context of stocks in the mid market cap category, UNITED THERAPEUTICS Corp's variance in analysts' estimates is lower than -425.54% of them.

Stocks similar to UNITED THERAPEUTICS Corp in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TGTX, TBPH, and TARO.

What is the outlook for UTHR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3699 seconds.